CASP1 and inflammatory bowel disease: In patients with IBD, the NLRP3 inflammasome was activated, followed by increased mRNA and protein levels of IL-1β, caspase-1, and NLRP3, which in turn aggravated the severity of IBD (Mahida et al., 1989; Lazaridis et al., 2017).